These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Management of pediatric generalized pustular psoriasis using biologics: An evidence-based review. Sachdeva M; Rankin BD; Mufti A; Yeung J; Vender R; Luca NJ; Miettunen P; Stevenson R; Devani AR; Prajapati VH J Am Acad Dermatol; 2022 Aug; 87(2):484-486. PubMed ID: 34695531 [No Abstract] [Full Text] [Related]
24. Guillain-Barré syndrome is associated with ixekizumab in a patient with pustular psoriasis. Liu H; Li Q; Li Q; Li X; Dai L Rheumatology (Oxford); 2023 May; 62(5):e161-e163. PubMed ID: 36269188 [No Abstract] [Full Text] [Related]
25. Generalized pustular psoriasis (von Zumbusch). Romiti R; Hirayama ALDS; Arnone M; Magalhães RF An Bras Dermatol; 2022; 97(1):63-74. PubMed ID: 34838431 [TBL] [Abstract][Full Text] [Related]
27. Combination therapy with biologic and colchicine for generalized pustular psoriasis. Taguchi R; Takamura S; Teraki Y Int J Dermatol; 2020 Nov; 59(11):e400-e402. PubMed ID: 32492187 [No Abstract] [Full Text] [Related]
28. Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors. Maçães CO; Lé AM; Torres T J Dermatolog Treat; 2022 Nov; 33(7):2911-2918. PubMed ID: 35695278 [TBL] [Abstract][Full Text] [Related]
29. Generalized pustular psoriasis: the case for rare disease and orphan designation. Koren J; Mburu S; Trigos D; Damiani G; Naldi L Br J Dermatol; 2022 Sep; 187(3):411-413. PubMed ID: 35257372 [TBL] [Abstract][Full Text] [Related]
30. Successful Secukinumab treatment of generalized pustular psoriasis and erythrodermic psoriasis. Mugheddu C; Atzori L; Lappi A; Pau M; Murgia S; Rongioletti F J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):e420-e421. PubMed ID: 28319281 [No Abstract] [Full Text] [Related]
31. Successful treatment of refractory juvenile generalized pustular psoriasis with secukinumab monotherapy: A case report and review of published work. Ho PH; Tsai TF J Dermatol; 2018 Nov; 45(11):1353-1356. PubMed ID: 30230584 [TBL] [Abstract][Full Text] [Related]
32. Secukinumab for the treatment of generalized pustular psoriasis: A case report. Li J; Gao X; Ma L; Fang Y Medicine (Baltimore); 2023 May; 102(18):e33693. PubMed ID: 37144985 [TBL] [Abstract][Full Text] [Related]
33. Reactivation of pustular psoriasis following mRNA vaccination versus COVID-19 infection: An overlap?: Reply to "Generalized pustular psoriasis following COVID-19" by Dadras MS et al.: Reply to "Generalized pustular psoriasis following COVID-19" by Dadras MS et al. Almeida RO; Hanemann T; Peres FLX; Escobar GF; Rangel Bonamigo R Dermatol Ther; 2022 Dec; 35(12):e15892. PubMed ID: 36193726 [No Abstract] [Full Text] [Related]
34. Generalized pustular psoriasis with deficiency of interleukin-36 receptor antagonist associated with sensorineural hearing impairment. Ichiyama S; Sugiura K; Hoashi T; Kanda N; Saeki H J Dermatol; 2021 Sep; 48(9):e470-e471. PubMed ID: 34117653 [No Abstract] [Full Text] [Related]
35. Successful treatment of a 3-year-old girl with generalized pustular psoriasis using secukinumab monotherapy. Zhu H; Song P; Du D; Tian H Pediatr Dermatol; 2021 Sep; 38(5):1366-1367. PubMed ID: 34515373 [TBL] [Abstract][Full Text] [Related]
36. Current trend in the treatment of generalized pustular psoriasis in Japan: Results from a questionnaire-based epidemiological study. Hayama K; Fujita H; Terui T J Dermatol; 2022 Dec; 49(12):e439-e440. PubMed ID: 35876178 [No Abstract] [Full Text] [Related]
37. Annular pustular psoriasis. Rogel-Vence M; González-Ruiz L; Santiago Sánchez-Mateos JL Med Clin (Barc); 2020 Oct; 155(7):326. PubMed ID: 31506201 [No Abstract] [Full Text] [Related]